Trial Profile
A double-blind, cross-over patient preference study of frovatriptan versus rizatriptan for the acute treatment of migraine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2011
Price :
$35
*
At a glance
- Drugs Frovatriptan (Primary) ; Rizatriptan
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Sponsors Istituto Lusofarmaco
- 25 May 2011 New trial record